Concourse Financial Group Securities, Inc. Scholar Rock Holding Corp Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding SRRK
# of Institutions
169Shares Held
73.7MCall Options Held
501KPut Options Held
26.3K-
Artal Group S.A. Luxembourg, N411.3MShares$104 Million10.78% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.21MShares$75.5 Million0.02% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$62.5 Million38.03% of portfolio
-
Redmile Group, LLC San Francisco, CA6.42MShares$59.1 Million4.49% of portfolio
-
Black Rock Inc. New York, NY5.01MShares$46.1 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $475M
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...